Skip to main content
Oxurion NV logo

Oxurion NV — Investor Relations & Filings

Ticker · OXUR ISIN · BE0974487192 LEI · 549300VWY8KVDFKLDM59 BR Professional, scientific and technical activities
Open in API
Filings indexed 1,031 across all filing types
Latest filing 2024-12-19 M&A Activity
Country BE Belgium
Listing BR OXUR

About Oxurion NV

https://oxurion.com/

Oxurion NV is a company focused on acquiring majority stakes in European pharmaceutical subcontractors. Its strategy is to build an integrated group of contract service providers to support healthcare stakeholders. A key asset in its portfolio is a majority stake in Axiodis CRO, a contract research organization specializing in biometrics. This investment-based business model represents a strategic pivot from the company's former focus on the internal research and development of therapies for retinal diseases such as Geographic Atrophy (GA) and Age-related Macular Degeneration (AMD).

Recent filings

Filing Released Lang Actions
OXUR_MA Update Market Notice_FR_20241219.pdf
M&A Activity Classification · 99% confidence The document is a press release dated December 19, 2024, announcing that French authorities have approved a 'strategic transaction' planned by Oxurion, subject to specific conditions. It discusses regulatory approval, next steps to finalize the transaction, and mentions that further updates will follow. This type of announcement, concerning a major corporate action like a merger or acquisition (even if the approval is just one step), falls under M&A Activity (TAR). However, since the text is a brief announcement about a regulatory step in a larger corporate action (transaction/deal) and does not contain the full details of a merger proposal or takeover bid itself, it could also be considered a general Regulatory Filing (RNS) or a Capital/Financing Update (CAP) if the transaction was purely financial. Given the context of 'transaction stratégique' and regulatory approval, TAR (M&A Activity) is the most specific fit for a deal-related announcement. If the transaction was a takeover bid, TAR is correct. If it was a major financing/restructuring, CAP might apply. Since it is a specific announcement about a deal progressing through regulatory hurdles, TAR is the best fit among the specific options, although RNS is a possibility if it's just a procedural update. Given the focus on a 'transaction stratégique', I will classify it as TAR, as it relates to corporate restructuring/deals.
2024-12-19 French
OXUR_MA Update Market Notice_NL_20241219.pdf
M&A Activity Classification · 99% confidence The document is a press release dated December 19, 2024, announcing that French authorities have approved a strategic transaction for Oxurion NV under specific conditions. It discusses regulatory approval, strategic repositioning, and the expected finalization date of the transaction. This type of announcement, concerning a major corporate action like a strategic transaction approval, fits best under the category of M&A Activity (TAR) or potentially Capital/Financing Update (CAP) if the transaction is primarily financial restructuring. Given the context of a 'strategic transaction' involving regulatory approval, it strongly suggests a merger, acquisition, or significant corporate restructuring event. Since 'M&A Activity (TAR)' covers merger proposals or takeover bids, and this is an approval step in a major strategic transaction, TAR is the most appropriate fit. It is not an earnings release (ER), an interim report (IR), or a general regulatory filing (RNS) because it is highly specific to a corporate transaction.
2024-12-19 Dutch
OXUR-Transparency-Notification-EN-20241212.pdf
Major Shareholding Notification Classification · 98% confidence The document is a press release from Oxurion NV announcing that it received a 'transparency notification' from Atlas Special Opportunities, LLC, detailing a change in shareholding that crossed a regulatory threshold (15%) under Belgian Transparency legislation. The annex explicitly labels the content as 'Form TR-1 BE' and 'Transparency notification'. This type of filing reports personal share transactions by major shareholders or executives, which aligns directly with the definition of Director's Dealing (DIRS) or, more broadly, Major Shareholding Notification (MRQ). Since the notification is specifically about crossing a major shareholding threshold (15%) by an external entity, 'Major Shareholding Notification' (MRQ) is the most precise fit, although 'Director's Dealing' (DIRS) often covers insider trades, MRQ covers significant changes by any party required to notify. Reviewing the definitions: - DIRS: Report of personal share transactions by company directors and executives (insider trades). - MRQ: Notification of changes in significant share ownership levels (crossing thresholds). The document explicitly discusses crossing a threshold (15%) due to the sale of voting securities by Atlas Special Opportunities, LLC. Therefore, MRQ is the correct classification.
2024-12-12 English
OXUR-Transparency-Notification-NL-20241212.pdf
Director's Dealing Classification · 98% confidence The document is a press release from Oxurion announcing receipt of a 'transparantiekennisgeving' (transparency notification) from Atlas Special Opportunities LLC, detailing a change in shareholding that caused them to fall below the 15% threshold, as required by Belgian transparency legislation (Wet van 2 mei 2007). The core content is the notification itself, which details insider trading/share ownership changes by a director or major shareholder. This directly corresponds to the definition of Director's Dealing (DIRS) or Major Shareholding Notification (MRQ). Since the notification explicitly details the change in voting rights/shareholding percentage crossing a regulatory threshold (15%), it fits the 'Major Shareholding Notification' (MRQ) category best, as it concerns significant ownership changes rather than just a single director's personal transaction (DIRS). The document is an announcement of this filing, but given its length and detailed annex (ANNEX 1, Form TR-1 BE), it functions as the primary disclosure of the event, making MRQ more appropriate than RPA or RNS.
2024-12-12 Dutch
OXUR-Transparency-Notification-EN-20241209.pdf
Director's Dealing Classification · 98% confidence The document is a press release announcing that Oxurion NV received 'transparency notifications' from Atlas Special Opportunities, LLC regarding changes in share ownership that crossed regulatory thresholds (20%). The annex explicitly references 'Transparency notification Form TR-1 BE' and Belgian Transparency legislation (Law of 2 May 2007 on disclosure of major holdings). This type of filing specifically reports changes in significant shareholdings by investors, which directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it involves voting rights, the core subject is the notification of crossing a major holding threshold, not the results of a vote (DVA) or director dealing (DIRS).
2024-12-09 English
OXUR-Transparency-Notification-NL-20241209.pdf
Major Shareholding Notification Classification · 98% confidence The document is a press release from Oxurion announcing that it received 'transparantiekennisgevingen' (transparency notifications) from Atlas Special Opportunities LLC regarding changes in share ownership that crossed regulatory thresholds (20%). The text explicitly references Belgian transparency legislation (Wet van 2 mei 2007) and includes an annex detailing a 'Form TR-1 BE' regarding the 'Acquisition or disposal of voting securities or voting rights'. This type of filing, which reports changes in significant shareholdings crossing specific thresholds, directly corresponds to the definition of Major Shareholding Notification (MRQ).
2024-12-09 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.